Daxor (DXR) announced the expansion of its blood volume analysis at two hospitals within New Jersey’s largest academic health care system. Based on current market momentum and expanding pipeline of opportunities, the company expects to maintain this accelerated sales trajectory throughout 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DXR: